中国医疗集团（08225）在2026年7月6日发布的月报显示，截至2026年6月30日，公司注册股本维持在100亿股，面值每股0.1港元，总注册股本为10亿港元。报告期末已发行股份总数为995,351,660股，与上月结余相同，未见新增发行或回购注销等活动，库存股数亦无变化。
根据公告，公司仍满足香港联交所相关的公众持股量规定；报告期内适用的董事会批准及上市规则、法律和其他监管要求均已严格遵循。公司所持有的已批出股票期权为25,380,000份，同样无增减变动，相关期权授予计划于2015年6月30日获得股东大会通过。
公告由公司董事会主席郭夏签署。至6月底，公司股本结构及发行量总体保持不变。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.